Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 4Lymphoid 4Breast 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1NET 1Gastrointestinal 1Endocrine 1Classical hematology 1

Conditions

Breast Neoplasms 66Neutropenia 16Triple Negative Breast Neoplasms 8Breast Neoplasms, Male 6Inflammatory Breast Neoplasms 4Ovarian Neoplasms 3Lung Neoplasms 3Neoplasms 2Febrile Neutropenia 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Pain 1Melanoma 1Lymphoma, Non-Hodgkin 1Locally Advanced Breast Cancer 1HER2-positive Breast Cancer 1HER2-Positive Early Stage Breast Cancer 1Fever 1Early Stage Breast Cancer 1Colorectal Neoplasms 1Chemotherapy-Induced Febrile Neutropenia 1Carcinoma, Renal Cell 1Carcinoma 1Breast Diseases 1Breast Cancer Metastatic 1Breast Cancer Female 1Adenocarcinoma 1

Interventions

Paclitaxel 26pembrolizumab 24Docetaxel 20Capecitabine 19Fulvestrant 17Trastuzumab 16Anastrozole 15Cyclophosphamide 14Lapatinib 13Letrozole 11Carboplatin 11Radiotherapy 10Doxorubicin 10palbociclib 9Therapeutics 9Nivolumab 9Exercise 9Gemcitabine 8Cisplatin 8Blood Specimen Collection 8Tamoxifen 7Bevacizumab 7liposomal doxorubicin 6exemestane 6abemaciclib 6Vinorelbine 6Standard of Care 6Fluorouracil 6atezolizumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × pegfilgrastim × Breast × Clear all
NCT01416389 2019-09-18

A Study of LY2523355 in Participants With Breast Cancer

Eli Lilly and Company

Phase 2 Completed
39 enrolled 16 charts
Breast

Breast Neoplasms, Neoplasms, Recurrence

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Amgen

Phase 2 Completed
Breast

Breast Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡